This website’s original language is English. For translation, click the globe icon or choose Translate in the menu.
10 matching records found
Brian Schwartz, CEO of H.I.G. Capital, joins Dani Burger on "Bloomberg Deals." They discussed how private equity managers have struggled to sell assets amid higher borrowing costs and weaker valuations. (Source: Bloomberg)
Canaccord Genuity Group Inc. is in talks to sell its UK wealth management business to a consortium led by private equity firm Centerbridge Partners, according to people with knowledge of the matter.
Partners Group Holding AG is reducing management fees at a key evergreen fund as it seeks investor approval to revamp the private equity vehicle.
US private equity giant Carlyle Group said its agreement to buy most of Lukoil PJSC foreign assets has terminated.
Tikehau Capital Co-Founder Mathieu Chabran says future performance of private credit and private equity will be driven far more by underwriting discipline, downside protection and operational value creation. He speaks with Paul Allen from the sidelines of '2026 Milken Institute Asia Summit'. (Source: Bloomberg)
David Friedland, co-head of North America investment banking at Citi, says private equity firms are still aggressively poaching young bankers from Wall Street banks. He talks about Citi’s plan to accelerate promotions and provide higher pay to its junior bankers. (Source: Bloomberg)
Warburg Pincus CEO, Jeffrey Perlman, says Japan is undergoing structural changes that are making the country more attractive to global private equity firms. He spoke exclusively on Bloomberg's Insight with Haslinda Amin about the opportunities emerging in the Japanese market. (Source: Bloomberg)
Singaporean state-owned investor Temasek Holdings has acquired a 9% stake in the management company of Italian private equity firm FSI for an undisclosed amount, according to a joint statement. It will also invest in the firm’s future funds.
Ingenia Communities Group will assess a a new, higher takeover bid from private equity group Warburg Pincus and its affiliates, the company said Monday.
Kobayashi Pharmaceutical Co., the Japanese health products company that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion ($3.2 billion) by private equity investors.